Levesque Jean-Pierre, Liu Fulu, Simmons Paul J, Betsuyaku Tomoko, Senior Robert M, Pham Christine, Link Daniel C
Stem Cell Biology Laboratory, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Blood. 2004 Jul 1;104(1):65-72. doi: 10.1182/blood-2003-05-1589. Epub 2004 Mar 9.
Recent evidence suggests that protease release by neutrophils in the bone marrow may contribute to hematopoietic progenitor cell (HPC) mobilization. Matrix metalloproteinase-9 (MMP-9), neutrophil elastase (NE), and cathepsin G (CG) accumulate in the bone marrow during granulocyte colony-stimulating factor (G-CSF) treatment, where they are thought to degrade key substrates including vascular cell adhesion molecule-1 (VCAM-1) and CXCL12. To test this hypothesis, HPC mobilization was characterized in transgenic mice deficient in one or more hematopoietic proteases. Surprisingly, HPC mobilization by G-CSF was normal in MMP-9-deficient mice, NE x CG-deficient mice, or mice lacking dipeptidyl peptidase I, an enzyme required for the functional activation of many hematopoietic serine proteases. Moreover, combined inhibition of neutrophil serine proteases and metalloproteinases had no significant effect on HPC mobilization. VCAM-1 expression on bone marrow stromal cells decreased during G-CSF treatment of wild-type mice but not NE x CG-deficient mice, indicating that VCAM-1 cleavage is not required for efficient HPC mobilization. G-CSF induced a significant decrease in CXCL12 alpha protein expression in the bone marrow of Ne x CG-deficient mice, indicating that these proteases are not required to down-regulate CXCL12 expression. Collectively, these data suggest a complex model in which both protease-dependent and -independent pathways may contribute to HPC mobilization.
近期证据表明,骨髓中嗜中性粒细胞释放的蛋白酶可能有助于造血祖细胞(HPC)的动员。在粒细胞集落刺激因子(G-CSF)治疗期间,基质金属蛋白酶-9(MMP-9)、中性粒细胞弹性蛋白酶(NE)和组织蛋白酶G(CG)在骨髓中积聚,据认为它们会降解包括血管细胞黏附分子-1(VCAM-1)和CXCL12在内的关键底物。为了验证这一假设,对缺乏一种或多种造血蛋白酶的转基因小鼠的HPC动员情况进行了表征。令人惊讶的是,在MMP-9缺陷小鼠、NE×CG缺陷小鼠或缺乏二肽基肽酶I(许多造血丝氨酸蛋白酶功能激活所需的一种酶)的小鼠中,G-CSF诱导的HPC动员是正常的。此外,联合抑制嗜中性粒细胞丝氨酸蛋白酶和金属蛋白酶对HPC动员没有显著影响。在野生型小鼠接受G-CSF治疗期间,骨髓基质细胞上的VCAM-1表达下降,但NE×CG缺陷小鼠则不然,这表明高效的HPC动员不需要VCAM-1的裂解。G-CSF导致Ne×CG缺陷小鼠骨髓中CXCL12α蛋白表达显著下降,这表明下调CXCL12表达不需要这些蛋白酶。总体而言,这些数据提示了一个复杂的模型,其中蛋白酶依赖性和非依赖性途径都可能有助于HPC动员。